Versant Ventures V LLC 13D and 13G filings for Aprea Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 8:44 pm Sale | 2021-12-31 | 13G | Aprea Therapeutics, Inc. APRE | Versant Ventures V LLC | 0 0.000% | -58,777 (Position Closed) | Filing |
| 2021-02-16 07:32 am Sale | 2020-12-31 | 13G | Aprea Therapeutics, Inc. APRE | Versant Ventures V LLC | 58,777 5.500% | -67,189 (-53.34%) | Filing |